Integrated Filing — IndAS



General information about company

Scrip Code 523642
NSE Symbol PIIND
MSEI Symbol NOTLISTED
ISIN INE603J01030
Name of company PI INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-02-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 12-02-2026   14:00:00
End date and time of board meeting 12-02-2026   18:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 1,37,570.00 5,14,850.00
Other income 6,670.00 23,510.00
Total income 1,44,240.00 5,38,360.00
2 Expenses
(a) Cost of materials consumed 67,160.00 2,32,100.00
(b) Purchases of stock-in-trade 3,620.00 15,190.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (14,390.00) (29,950.00)
(d) Employee benefit expense 22,810.00 68,090.00
(e) Finance costs 620.00 1,270.00
(f) Depreciation, depletion and amortisation expense 10,540.00 29,990.00
(f) Other Expenses
1 Net Impairment losses on Financial Assets 850.00 2,430.00
2 Power, Fuel & Water 6,370.00 20,760.00
3 Environment & Pollution Control Expenses 2,480.00 9,100.00
4 Freight & Cartage 350.00 3,060.00
5 Advertisement & Sales Promotion 2,590.00 6,970.00
6 Travelling and Conveyance 2,870.00 7,760.00
7 Legal & professional fees 1,570.00 7,820.00
8 Repairs & Maintenance 3,710.00 10,460.00
9 Laboratory & Testing Charges 1,520.00 3,600.00
10 Other Expenses 5,830.00 21,190.00
Total other expenses 28,140.00 93,150.00
Total expenses 1,18,500.00 4,09,840.00
3 Total profit before exceptional items and tax 25,740.00 1,28,520.00
4 Exceptional items 10,510.00 10,510.00
5 Total profit before tax 36,250.00 1,39,030.00
6 Tax expense
7 Current tax 6,520.00 27,050.00
8 Deferred tax (1,360.00) 450.00
9 Total tax expenses 5,160.00 27,500.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 31,090.00 1,11,530.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 40.00 530.00
16 Total profit (loss) for period 31,130.00 1,12,060.00
17 Other comprehensive income net of taxes 780.00 2,020.00
18 Total Comprehensive Income for the period 31,910.00 1,14,080.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 31,130.00 1,12,060.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 780.00 2,020.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 1,520.00 1,520.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 20.52 73.87
Diluted earnings (loss) per share from continuing operations 20.52 73.86
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 20.52 73.87
Diluted earnings (loss) per share from continuing and discontinued operations 20.52 73.86
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Agro Chemicals 1,31,780.00 4,95,560.00
2 Pharma 5,990.00 19,570.00
3 Inter Segment Adjustment 0.00 0.00
Total Segment Revenue 1,37,770.00 5,15,130.00
Less: Inter segment revenue 200.00 280.00
Revenue from operations 1,37,570.00 5,14,850.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Agro Chemicals 28,790.00 1,44,420.00
2 Pharma 5,800.00 (9,990.00)
3 Inter Segment Adjustment 1,700.00 5,130.00
Total Profit before tax 36,290.00 1,39,560.00
i. Finance cost 0.00 0.00
ii. Other Unallocable Expenditure net off Unallocable income 0.00 0.00
Profit before tax 36,290.00 1,39,560.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Agro Chemicals 11,90,680.00 11,90,680.00
2 Pharma 1,40,120.00 1,40,120.00
3 Inter Segment Adjustment 0.00 0.00
Total Segment Asset 13,30,800.00 13,30,800.00
Un-allocable Assets 0.00 0.00
Net Segment Asset 13,30,800.00 13,30,800.00
4 Segment Liabilities
Segment Liabilities
1 Agro Chemicals 1,81,380.00 1,81,380.00
2 Pharma 34,840.00 34,840.00
3 Inter Segment Adjustment 0.00 0.00
Total Segment Liabilities 2,16,220.00 2,16,220.00
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 2,16,220.00 2,16,220.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements gain/(loss) on defined benefit plans 680.00 870.00
Total Amount of items that will not be reclassified to profit and loss 680.00 870.00
2 Income tax relating to items that will not be reclassified to profit or loss 230.00 290.00
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain/(loss) on cashflow hedges (1,220.00) (9,720.00)
2 Exchange difference on translation of foreign operations 1,130.00 7,760.00
Total Amount of items that will be reclassified to profit and loss (90.00) (1,960.00)
4 Income tax relating to items that will be reclassified to profit or loss (420.00) (3,400.00)
5 Total Other comprehensive income 780.00 2,020.00